Content by University of California - Santa Cruz
|4 min read
Nobel-Winning Scientist Challenges Consensus on Telomere Length Patterns
“Jaw dropping” findings suggest there are yet undiscovered mechanisms for telomere length regulation, offering hope for treating cancer and degenerative disease
|4 min read
Testing for Noncoding RNA Improves Cancer Detection
A novel liquid biopsy technology leverages cell-free RNA “dark matter” to enhance cancer diagnosis
|3 min read
Novel Method Automates the Growth of Brain Tissue Organoids on a Chip
The new system can increase reproducibility in cerebral organoid research and lower the levels of cellular stress
|3 min read
COVID-19 Genomic Recombination Often Occurs in Spike Protein Region
Researchers developed an open source software for tracking instances of recombination
|4 min read
New Data Sharing Technique Will Enable Better Understanding of Genetic Variants
Using federated analysis can lead scientists to a more nuanced understanding of heritable disease
|3 min read
Ultrasensitive Antigen Test Detects SARS-CoV-2 and Influenza A
The novel chip-based test can detect the viruses that cause COVID-19 and flu with a single test
|4 min read
New Serological Assay Provides Rapid, Accurate Testing for SARS-CoV-2 Antibodies
Using optical biosensor technology, the test provides quantitative measurements of antibodies in less than 20 minutes
|4 min read
Cholera Studies Reveal Mechanisms of Biofilm Formation and Hyperinfectivity
A series of publications from microbiologist Fitnat Yildiz's lab provides new understanding of cholera biofilms and why the bacteria in biofilms are so highly infectious
|3 min read
New High-Throughput Approach Yields Libraries of Probes for Immunological Assays
Technical innovation enables rapid assessment of T cell repertoires for research and diagnostics, with potential applications in studying COVID-19 immune responses
|3 min read
Pediatric Cancer Study Shows Usefulness of Gene Expression Analysis
Comparative RNA sequencing analysis, conducted across four precision medicine studies, was feasible and potentially useful for 68 percent of children with cancerPage 1 of 1
